Navigation Links
Watchdog to Be Set on Oral Chemotherapy, Warns Experts

A survey conducted by Dana-Farber Cancer Institute in Boston, Massachusetts has come out with findings that oral chemotherapy drugs need to be monitored, prescribed and// coordinated in a better way.

Listing cases of unfortunate events, sourced from the institutes that participated in the research, Dr Lawrence Shulman, of the Dana-Farber Cancer Institute, said findings underline the importance of forging a consensus in the oncology field on standardized safeguards and practices for prescribing and monitoring the use of these drugs.

Many centers had no formal system for monitoring patients taking the drugs, which are becoming increasingly popular internationally.

"Given how quickly oral chemotherapies have become standard care for a growing number of cancers, we were not surprised to find variations in how organizations prescribe and monitor the use of these agents," said Dr Saul Weingart, the president of patient safety at Dana-Farber.

An example was that on prescriptions for the six most common oral chemotherapies: Only 26 percent of the centers required a patient's diagnosis; only 9 percent required a patient's treatment schedule and length of treatment; and only 9 percent required a patient's body surface area calculation, which is used to determine correct and safe drug dose.

The researchers found that almost 70 percent of the centers used handwritten orders for most of the oral chemotherapy prescriptions, 5 percent used preprinted paper prescriptions, and 14 percent used computer-based prescription order entry systems.

Yet another expert thinks that cancer centers need to treat oral chemotherapy drugs in the same way they treat intravenous ones.

"We can't assume that because a drug is an oral drug it is going to be properly prescribed, properly dispensed and properly confirmed that the patient has taken it," said Dr. Len Lichtenfeld, deputy chief medical officer at the American Cancer Societ y. "This study raises the question whether we, as doctors, need to be more vigilant."
ANN
'"/>




Related medicine news :

1. Pets As Disease Watchdogs
2. Health Watchdog Advises a Rethink on NHS Cancer Services
3. Carcinogens in Fish Worries Chinese Watchdogs
4. Drugs Watchdog Faces A Judicial Review
5. Radiation And Chemotherapy, A Better Option For Head And Neck Cancer
6. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
7. Study Warns About The Use Of Popular Asthma Drug To Stop Childrens Coughs
8. ADB Report Warns of Bird-Flu Catastrophe
9. FDA Warns Against Birth-Control Patch
10. Charlotte Church Warns kiss n tell girls not to flirt with Henson
11. UK Committee Warns on Food Shortages Due to Flu Epidemic
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/21/2017)... ... January 21, 2017 , ... Salveo for life, a company that ... product to the United States as part of its presence to expand its market ... aims to reduce the productions of nasty toxins as a result of drinking alcohol, ...
(Date:1/21/2017)... ... January 21, 2017 , ... Phytocéane invites you to take ... rest of the world with ZANZIBAR SHOWER GEL. Inspired by the beauty of Zanzibar, ... Coconut Oil and moisturizing vegetal coral to create this gentle, crystal-clear shower gel to ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... new medical office in Petaluma, located at 167 Lynch Creek Way. The Petaluma ... SRO sports medicine and rehabilitation services and on-site x-ray services. Two ...
(Date:1/20/2017)... ... ... Launches New ADA Portable Motion Trek BP 300 Lift. Built for durability, this pool lift ... can be wheeled out of the way and stored when not in use. It is ... the feedback from customers into specific enhancements and created a new product that is built ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a ... percent pure essential oils, announced the company had a successful visit to the 2017 ... ECRM event gives companies that work in the nutritional, sports and health industries a ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA ... drugs market is expected to grow at a CAGR of ... of 38.7% in the second half of the forecast period. The ... 2016 to 2027. The market is estimated at $1,058 million in ... ...
(Date:1/19/2017)... James Gilbart , ... 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... recently in a supplement to European Oncology & ... article by James Gilbart and ...
(Date:1/19/2017)... , Jan. 19, 2017   Science Exchange ... excited to announce that the first five replication ...  (RP:CB) have been published in eLife today. Despite ... represents the first practical evaluation of reproducibility rates ... reproducible studies. Unlike other assessments of reproducibility, the ...
Breaking Medicine Technology: